CLOV vs. VOYA, JXN, ESNT, ACT, PLMR, BWIN, FG, GSHD, OSCR, and BHF
Should you be buying Clover Health Investments stock or one of its competitors? The main competitors of Clover Health Investments include Voya Financial (VOYA), Jackson Financial (JXN), Essent Group (ESNT), Enact (ACT), Palomar (PLMR), The Baldwin Insurance Group (BWIN), F&G Annuities & Life (FG), Goosehead Insurance (GSHD), Oscar Health (OSCR), and Brighthouse Financial (BHF). These companies are all part of the "insurance" industry.
Clover Health Investments vs.
Clover Health Investments (NASDAQ:CLOV) and Voya Financial (NYSE:VOYA) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment, community ranking and earnings.
In the previous week, Voya Financial had 9 more articles in the media than Clover Health Investments. MarketBeat recorded 11 mentions for Voya Financial and 2 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 1.77 beat Voya Financial's score of 0.79 indicating that Clover Health Investments is being referred to more favorably in the media.
19.8% of Clover Health Investments shares are owned by institutional investors. Comparatively, 96.1% of Voya Financial shares are owned by institutional investors. 24.1% of Clover Health Investments shares are owned by company insiders. Comparatively, 1.0% of Voya Financial shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Voya Financial has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Voya Financial, indicating that it is currently the more affordable of the two stocks.
Clover Health Investments has a beta of 1.91, indicating that its share price is 91% more volatile than the S&P 500. Comparatively, Voya Financial has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500.
Voya Financial received 595 more outperform votes than Clover Health Investments when rated by MarketBeat users. Likewise, 67.47% of users gave Voya Financial an outperform vote while only 41.07% of users gave Clover Health Investments an outperform vote.
Clover Health Investments currently has a consensus target price of $4.83, suggesting a potential upside of 60.84%. Voya Financial has a consensus target price of $81.92, suggesting a potential upside of 20.49%. Given Clover Health Investments' stronger consensus rating and higher probable upside, research analysts plainly believe Clover Health Investments is more favorable than Voya Financial.
Voya Financial has a net margin of 8.29% compared to Clover Health Investments' net margin of -5.92%. Voya Financial's return on equity of 14.10% beat Clover Health Investments' return on equity.
Summary
Voya Financial beats Clover Health Investments on 12 of the 18 factors compared between the two stocks.
Get Clover Health Investments News Delivered to You Automatically
Sign up to receive the latest news and ratings for CLOV and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Clover Health Investments Competitors List
Related Companies and Tools
This page (NASDAQ:CLOV) was last updated on 6/10/2025 by MarketBeat.com Staff
